127 related articles for article (PubMed ID: 17502568)
1. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting.
Schillinger M; Sabeti S; Dick P; Amighi J; Mlekusch W; Schlager O; Loewe C; Cejna M; Lammer J; Minar E
Circulation; 2007 May; 115(21):2745-9. PubMed ID: 17502568
[TBL] [Abstract][Full Text] [Related]
2. Primary Stenting of the Superficial Femoral Artery in Patients with Intermittent Claudication Has Durable Effects on Health-Related Quality of Life at 24 Months: Results of a Randomized Controlled Trial.
Lindgren HIV; Qvarfordt P; Bergman S; Gottsäter A;
Cardiovasc Intervent Radiol; 2018 Jun; 41(6):872-881. PubMed ID: 29520431
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of outcomes from drug-eluting stent implantation in femoropopliteal arteries.
Li M; Tu H; Yan Y; Guo Z; Zhu H; Niu J; Yin M
PLoS One; 2023; 18(9):e0291466. PubMed ID: 37733656
[TBL] [Abstract][Full Text] [Related]
4. Smooth muscle cell-targeted RNA ligand promotes accelerated reendothelialization in a swine peripheral injury model.
Lei B; Liu LB; Stokes L; Giangrande PH; Miller FJ; Yazdani SK
Mol Ther Nucleic Acids; 2023 Dec; 34():102023. PubMed ID: 37727270
[TBL] [Abstract][Full Text] [Related]
5. Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: a meta-analysis.
Koeckerling D; Raguindin PF; Kastrati L; Bernhard S; Barker J; Quiroga Centeno AC; Raeisi-Dehkordi H; Khatami F; Niehot C; Lejay A; Szeberin Z; Behrendt CA; Nordanstig J; Muka T; Baumgartner I
Eur Heart J; 2023 Mar; 44(11):935-950. PubMed ID: 36721954
[TBL] [Abstract][Full Text] [Related]
6. Long coverage with drug-eluting stents is superior to spot coverage for long femoropopliteal artery disease: PARADE II study.
Park JI; Ko YG; Lee YJ; Lee SJ; Hong SJ; Ahn CM; Kim JS; Kim BK; Hong MK; Yu CW; Rha SW; Park JK; Min PK; Yoon CH; Lee SR; Park SH; Choi DH
Front Cardiovasc Med; 2022; 9():1022071. PubMed ID: 36337904
[TBL] [Abstract][Full Text] [Related]
7. Medical Therapy for Secondary Prevention of Atherothrombotic Events in Peripheral Artery Disease.
Morrison JT; Hsia J; Bonaca MP
Heart Int; 2021; 15(1):14-19. PubMed ID: 36277318
[TBL] [Abstract][Full Text] [Related]
8. State-of-the-Art Endovascular Therapies for the Femoropopliteal Segment: Are We There Yet?
Mosarla RC; Armstrong E; Bitton-Faiwiszewski Y; Schneider PA; Secemsky EA
J Soc Cardiovasc Angiogr Interv; 2022; 1(5):. PubMed ID: 36268042
[TBL] [Abstract][Full Text] [Related]
9. [Atherectomy in Peripheral Artery Disease: Current and Future].
Kwon Y; Kim J; Won JH; Kim SH; Kim JE; Park SJ
Taehan Yongsang Uihakhoe Chi; 2021 May; 82(3):551-561. PubMed ID: 36238795
[TBL] [Abstract][Full Text] [Related]
10. [Interventional Treatments for Femoropopliteal Arterial Disease and Recent Updates].
Kim M; Cho SB
Taehan Yongsang Uihakhoe Chi; 2021 May; 82(3):527-540. PubMed ID: 36238772
[TBL] [Abstract][Full Text] [Related]
11. Local intraluminal delivery of a smooth muscle-targeted RNA ligand inhibits neointima growth in a porcine model of peripheral vascular disease.
Yazdani SK; Lei B; Cawthon CV; Cooper K; Huett C; Giangrande PH; Miller FJ
Mol Ther Nucleic Acids; 2022 Sep; 29():577-583. PubMed ID: 36090749
[TBL] [Abstract][Full Text] [Related]
12. Excimer laser ablation combined with drug-coated balloon versus drug-coated balloon in the treatment of de novo atherosclerotic lesions in lower extremities (ELABORATE): study protocol for a real-world clinical trial.
Jiang X; Fan L; Chen B; Jiang J; Liu J; Qiao G; Ju S; Shi Y; Ma T; Lin C; Fang G; Guo D; Xu X; Dong Z; Fu W
BMC Cardiovasc Disord; 2022 Jul; 22(1):317. PubMed ID: 35842583
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-coated balloons angioplasties for extra-long femoropopliteal artery atherosclerotic lesions (> 30 cm):12 months outcomes from a single center.
Pan T; Zhang G; Liu Z; Zhang T; Li C; Ji D
J Interv Med; 2022 Feb; 5(1):28-31. PubMed ID: 35586286
[TBL] [Abstract][Full Text] [Related]
14. Macrophage Polarization as a Novel Therapeutic Target for Endovascular Intervention in Peripheral Artery Disease.
Tan RP; Ryder I; Yang N; Lam YT; Santos M; Michael PL; Robinson DA; Ng MK; Wise SG
JACC Basic Transl Sci; 2021 Aug; 6(8):693-704. PubMed ID: 34466756
[TBL] [Abstract][Full Text] [Related]
15. Structural Design of Vascular Stents: A Review.
Pan C; Han Y; Lu J
Micromachines (Basel); 2021 Jun; 12(7):. PubMed ID: 34210099
[TBL] [Abstract][Full Text] [Related]
16. Impact of chronic outward force on arterial responses of proximal and distal of long superficial femoral artery stent.
Li H; Rha SW; Choi BG; Choi SY; Moon SK; Jang WY; Kim W; Ahn JH; Park SH; Choi WG; Yang RF; Bai WW; Choi CU; Ryu YG; Baek MJ; Oh DJ
BMC Cardiovasc Disord; 2021 Jun; 21(1):323. PubMed ID: 34193057
[TBL] [Abstract][Full Text] [Related]
17. Influence of Infrapopliteal Runoff Vessels on Primary Patency after Superficial Femoral Artery Angioplasty with Stenting in Patients with Claudication.
Noh BG; Park YM; Choi JB; Lee BC; Lee SS; Jung HJ
Vasc Specialist Int; 2020 Dec; 36(4):233-240. PubMed ID: 33293487
[TBL] [Abstract][Full Text] [Related]
18. Comparison of morphometric, structural, mechanical, and physiologic characteristics of human superficial femoral and popliteal arteries.
Jadidi M; Razian SA; Anttila E; Doan T; Adamson J; Pipinos M; Kamenskiy A
Acta Biomater; 2021 Feb; 121():431-443. PubMed ID: 33227490
[TBL] [Abstract][Full Text] [Related]
19. Dose optimization of decellularized skeletal muscle extracellular matrix hydrogels for improving perfusion and subsequent validation in an aged hindlimb ischemia model.
Hernandez MJ; Zelus EI; Spang MT; Braden RL; Christman KL
Biomater Sci; 2020 Jun; 8(12):3511-3521. PubMed ID: 32432574
[TBL] [Abstract][Full Text] [Related]
20. Pre-Clinical Investigation of Keratose as an Excipient of Drug Coated Balloons.
Goel E; Erwin M; Cawthon CV; Schaff C; Fedor N; Rayl T; Wilson O; Christians U; Register TC; Geary RL; Saul J; Yazdani SK
Molecules; 2020 Mar; 25(7):. PubMed ID: 32244375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
